California Bill would require insurers to pay for HIV tests if signed by Gov. Schwarzenegger

Health care insurers will be required to cover routine HIV tests if a bill (AB 1894) passed by the California Legislature in August is signed by Gov. Arnold Schwarzenegger (R), the San Fernando Valley Business Journal reports.

According to the California Office of AIDS, about 40,000 Californians are HIV-positive but are not aware of their status. CDC figures show that about 40% of the U.S. population has ever received an HIV test.

Some supporters of the bill, by Assembly member Paul Krekorian (D), said that the lack of HIV testing sites puts more people at risk of HIV infection. In a statement, Krekorian said that the "important bill creates an environment in which testing will become routine and more Californians will know their HIV status, get linked to care as needed and have an overall better quality of life. Studies have shown that when individuals know their HIV status, those found to be positive take steps to decrease the risk of passing their HIV infections on to others. AB 1894 is a straightforward solution to a growing public health dilemma. It helps pave the way to encourage widespread and routine HIV testing throughout California -- something the CDC first recommended nationwide nearly two years ago. It is prudent legislation that will save lives."

The Journal reports that one reason CDC's suggestions have not been followed by some physicians is because the agency did not recommend who should pay for the tests, which cost about $20. Requiring insurers to cover HIV tests would make payment a "nonissue," according to the Journal (Kareem, San Fernando Valley Business Journal, 9/15).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HIV trial points to semaglutide as a new anti-aging contender